Live Breaking News & Updates on Colin kellaher

Stay informed with the latest breaking news from Colin kellaher on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Colin kellaher and stay connected to the pulse of your community

Pfizer Gets FDA OK For Beqvez Gene Therapy for Hemophilia B

By Colin Kellaher

Pfizer has won Food and Drug Administration approval of Beqvez, a one-time gene therapy for certain patients with the inherited bleeding disorder hemophilia B.

The New...

New-york , United-states , Colin-kellaher , Pfizer , Drug-administration , Dow-jones , Markets ,

Bristol Myers Gets CHMP Backing for Opdivo Combo in Bladder Cancer

By Colin Kellaher

Bristol Myers Squibb on Friday said the European Medicines Agency's Committee for Medicinal Products for Human Use recommended expanded approval of its blockbuster cancer...

Colin-kellaher , Bristol-myers-squibb , Bristol-myers , Drug-administration , European-commission , Myers-squibb , European-medicines-agency , Medicinal-products , Human-use , Dow-jones , Markets ,

Medtronic Gets FDA OK for Inceptiv Closed-Loop Spinal Cord Stimulator

By Colin Kellaher

Medtronic has won Food and Drug Administration approval of its Inceptiv closed-loop rechargeable spinal cord stimulator, or SCS, to treat chronic pain.

Medtronic on...

Dublin , Ireland , Japan , Colin-kellaher , Medtronic , Drug-administration , Dow-jones , Markets ,

Amgen to Seek European OK of Thyroid Eye Disease Drug Tepezza

By Colin Kellaher

Amgen plans to seek European regulatory approval for the sale of its blockbuster Tepezza treatment for thyroid eye disease.

The Thousand Oaks, Calif., biotechnology...

Colin-kellaher , European-medicines-agency , Drug-administration , Amgen , Thousand-oaks , Horizon-therapeutics , Dow-jones , Markets ,

Kansas City Fed Services Activity Index Moves Higher in April

By Colin Kellaher

Services activity in the middle of the U.S. expanded somewhat in April, and expectations for future activity remained steady, according to a monthly survey by the Federal...

Wyoming , United-states , Oklahoma , Kansas-city , Kansas , Missouri , Colorado , Nebraska , New-mexico , Colin-kellaher , Federal-reserve-bank , District-services

Regeneron Sets Crispr-Based Collaboration With Mammoth Biosciences

By Colin Kellaher

Regeneron Pharmaceuticals has inked a deal with privately held Mammoth Biosciences to research, develop and commercialize Crispr-based gene-editing therapies targeting ...

Colin-kellaher , Regeneron-pharmaceuticals , Mammoth-biosciences , Dow-jones ,

Bristol Myers Shedding 2,200 Jobs in Cost Savings Push

By Colin Kellaher

Bristol Myers Squibb on Thursday said it plans to cut more than 2,000 jobs as part of an initiative aimed at generating about $1.5 billion in cost savings by the end of next...

Bristol-myers , Colin-kellaher , Bristol-myers-squibb , Myers-squibb , Dow-jones , Markets ,

ImmunityBio Shares Soar Premarket on FDA Nod for Anktiva

By Colin Kellaher

Shares of ImmunityBio jumped more than 25% in premarket trading Tuesday after the immunotherapy company received Food and Drug Administration approval of its Anktiva...

San-diego , California , United-states , Colin-kellaher , Drug-administration , Bacillus-calmette-guerin , Dow-jones , Markets ,

Nordson Names Daniel Hopgood Chief Financial Officer

By Colin Kellaher

Nordson has hired Eaton executive Daniel Hopgood to succeed Joseph Kelley as the precision technology company's top finance executive.

Nordson on Tuesday said Hopgood,...

Ohio , United-states , Daniel-hopgood , Colin-kellaher , Joseph-kelley , Adam-wadecki , Eaton , Stephen-shamrock , Dow-jones ,

Vertex Pharmaceuticals in T1D Licensing Pact With TreeFrog Therapeutics

By Colin Kellaher

Vertex Pharmaceuticals has struck an exclusive licensing agreement with privately held TreeFrog Therapeutics in a bid to bolster production of its cell therapies for type-1...

France , Boston , Massachusetts , United-states , Colin-kellaher , Vertex-pharmaceuticals , Treefrog-therapeutics , Dow-jones , Markets ,